Molecular basis of group A streptococcal virulence

被引:353
作者
Bisno, AL
Brito, MO
Collins, CM
机构
[1] Vet Affairs Med Ctr, Miami, FL 33125 USA
[2] Univ Miami, Sch Med, Miami, FL 33125 USA
[3] Allegheny Gen Hosp, Div Infect Dis, Pittsburgh, PA USA
[4] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
关键词
D O I
10.1016/S1473-3099(03)00576-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The group A streptococcus (GAS) (Streptococcus pyogenes) is among the most common and versatile of human pathogens. It is responsible for a wide spectrum of human diseases, ranging from trivial to lethal. The advent of modern techniques of molecular biology has taught much about the organism's virulence, and the genomes of several GAS types have now been deciphered. Surface structures of GAS including a family of M proteins, the hyaluronic acid capsule, and fibronectin-binding proteins, allow the organism to adhere to, colonise, and invade human skin and mucus membranes under varying environmental conditions. M protein binds to complement control factors and other host proteins to prevent activation of the alternate complement pathway and thus evade phagocytosis and killing by polymorphonuclear leucocytes. Extracellular toxins, including superantigenic streptococal pyrogenic exotoxins, contribute to tissue invasion and initiate the cytokine storm felt responsible for illnesses such as necrotising fasciitis and the highly lethal streptococcal toxic shock syndrome. Progress has been made in understanding the molecular epidemiology of acute rheumatic fever but less is understood about its basic pathogenesis. The improved understanding of GAS genetic regulation, structure, and function has opened exciting possibilities for developing safe and effective GAS vaccines. Studies directed towards achieving this long-sought goal are being aggressively pursued.
引用
收藏
页码:191 / 200
页数:10
相关论文
共 150 条
[41]   High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements [J].
Dombek, PE ;
Cue, D ;
Sedgewick, J ;
Lam, H ;
Ruschkowski, S ;
Finlay, BB ;
Cleary, PP .
MOLECULAR MICROBIOLOGY, 1999, 31 (03) :859-870
[42]   PARAMETERS AFFECTING ADHERENCE AND TISSUE TROPISMS OF STREPTOCOCCUS-PYOGENES [J].
ELLEN, RP ;
GIBBONS, RJ .
INFECTION AND IMMUNITY, 1974, 9 (01) :85-91
[43]   Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates:: emm103 to emm124 [J].
Facklam, RF ;
Martin, DR ;
Lovgren, M ;
Johnson, DR ;
Efstratiou, A ;
Thompson, TA ;
Gowan, S ;
Kriz, P ;
Tyrrell, GJ ;
Kaplan, E ;
Beall, B .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :28-38
[44]   A response regulator that represses transcription of several virulence operons in the group A streptococcus [J].
Federle, MJ ;
McIver, KS ;
Scott, JR .
JOURNAL OF BACTERIOLOGY, 1999, 181 (12) :3649-3657
[45]   Identification of binding sites for the group A streptococcal global regulator CovR [J].
Federle, MJ ;
Scott, JR .
MOLECULAR MICROBIOLOGY, 2002, 43 (05) :1161-1172
[46]   Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: Secretory leukocyte proteinase inhibitor and lysozyme [J].
Fernie-King, BA ;
Seilly, DJ ;
Davies, A ;
Lachmann, PJ .
INFECTION AND IMMUNITY, 2002, 70 (09) :4908-4916
[47]   Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes [J].
Fernie-King, BA ;
Seilly, DJ ;
Willers, C ;
Würzner, R ;
Davies, A ;
Lachmann, PJ .
IMMUNOLOGY, 2001, 103 (03) :390-398
[48]   Complete genome sequence of an M1 strain of Streptococcus pyogenes [J].
Ferretti, JJ ;
McShan, WM ;
Ajdic, D ;
Savic, DJ ;
Savic, G ;
Lyon, K ;
Primeaux, C ;
Sezate, S ;
Suvorov, AN ;
Kenton, S ;
Lai, HS ;
Lin, SP ;
Qian, YD ;
Jia, HG ;
Najar, FZ ;
Ren, Q ;
Zhu, H ;
Song, L ;
White, J ;
Yuan, XL ;
Clifton, SW ;
Roe, BA ;
McLaughlin, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4658-4663
[49]   IMMUNOGENICITY OF LIPOSOME-BOUND HYALURONATE IN MICE - AT LEAST 2 DIFFERENT ANTIGENIC SITES ON HYALURONATE ARE IDENTIFIED BY MOUSE MONOCLONAL-ANTIBODIES [J].
FILLIT, HM ;
BLAKE, M ;
MACDONALD, C ;
MCCARTY, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :971-982
[50]   INDUCTION OF ANTIBODIES TO HYALURONIC-ACID BY IMMUNIZATION OF RABBITS WITH ENCAPSULATED STREPTOCOCCI [J].
FILLIT, HM ;
MCCARTY, M ;
BLAKE, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (03) :762-776